Listen to this story For five decades, protein folding has been one of the toughest problems in life science. The breakthrough came in 2020 when Google DeepMind successfully tackled this long-standing challenge with AlphaFold. This achievement not only marked a turning point but also unlocked a multitude of possibilities for leveraging AI in drug development and broader healthcare applications. Following AlphaFold’s success, other players entered the scene. Meta introduced ESMFold, while the Chinese biotech company Helixon pioneered OmegaFold. Generate Biomedicines contributed Chroma, and Baker Lab brought forth RoseTTAFold and RoseTTAFoldDiffusion, expanding the array of innovative solutions in this domain. And...